Imaging, Radiotherapy, Endoscopy, Ancillary Devices and Related Goods and Services

SCCL awarded a framework agreement for Imaging, Radiotherapy, Endoscopy, Ancillary Devices and Related Goods and Services on 1st April 2022 (the Framework Agreement). The Framework Agreement anticipated that at time of exercising the options to extend, specifications would be reviewed in light of technological advancements and market developments during the term with a view to re-open the Framework Agreement and invite new and existing suppliers to respond to a tender exercise that may award new suppliers and new products onto the Framework Agreement. In line with original invitation to tender SCCL is exercising that option to re-open the framework to products and suppliers not currently on the existing framework agreement. This PIN invites interest from suppliers to express interest in the forthcoming procurement exercise to join the Framework Agreement. Any supplier who is not currently awarded to a Framework Agreement will be required to meet specified requirements which include, and are not limited to, adhering to the equipment specification and industry standards, ability to provide product support, and financial requirements before appointment to the Framework Agreement. Precise quantities are unknown and is anticipated that initial expenditure will be between £700,000,000 to £1,000,000,000 in the first year of the extension period, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.